Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday that it has increased its quarterly dividend for the first quarter of 2023.
The company has reported an increase in quarterly dividend of 15% to USD1.13 per share on the outstanding common stock for the first quarter of 2023.
The dividend will be paid to shareholders of record at 15 February 2023 on 10 March 2023.
Roquefort Therapeutics advances novel siRNA therapeutics
Perrigo Company announces quarterly dividend
Amgen announces Q3 2023 dividend
McKesson Corporation boosts quarterly dividend by 15% to USD0.62 per share